Search

You searched for "Genital"

825 results found

Fusion Bx 2.0 targeted prostate biopsy solution receives CE Mark

4 November 2019 | Research & Development
Focal Healthcare, an innovator of image-guided prostate cancer technology, has received CE Mark for its Fusion BxTM 2.0 prostate fusion biopsy solution.

Prolapse surgery with mesh: where do we stand in 2017? An ICS update

1 November 2017 | | URO - Functional / Reconstructive Urology
Background Surgery for pelvic organ prolapse (POP) is common among women. The lifetime risk of undergoing at least one surgical procedure for POP is up to 20% [1]. This kind of surgery will be increasingly important due to an ageing...

A practical guide to success in National Selection

1 January 2014 | | URO - Core Urology
Gidon Ellis and Jonathan Makanjuola were both selected at National Selection in 2012 for Urological Higher Surgical Training. Both were ranked first in their respective interview rounds that year. It is no mean feat. Having read their article – their...

EMUC24 (European Multidisciplinary Congress on Urological Cancers) Congress

7 November 2024 -10 November 2024
Top experts in medical oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology gather at the congress to offer insights on the best practices, developments on major trials, and breakthroughs.

EAU (European Association of Urology) Talent Incubator Programme: Policy & Innovation

22 November 2024 -23 November 2024
The randomised controlled trial (RCT) will remain one of the most important methods for medical advancements. A solid framework, an extensive network and financial resources are key factors in the success of a trial. In this module of the Talent Incubator Programme, we will address the practical side of conducting research and trials with support from policy experts, industry representatives and patient advocates

EMS Benign prostatic hyperplasia (BPH) Masterclass

10 September 2024 -11 September 2024
The Masterclass comprises a combination of didactic presentations, as-live surgery presentations, and live case observation on surgical techniques, tips and tricks, and the medical management of Benign prostatic hyperplasia (BPH) patients.

EMS Benign prostatic hyperplasia (BPH)

18 September 2024 -19 September 2024
The Masterclass comprises a combination of didactic presentations, as-live surgery presentations, and live case observation on surgical techniques, tips and tricks, and the medical management of Benign prostatic hyperplasia (BPH) patients.

EMS Prostate Enucleation by TFL – Step by Step Guide

19 October 2024 -20 October 2024
The EMS and Metro Specialist Hospital teams in Malaysia are thrilled to welcome you to our 1.5- day program that focuses on advanced techniques for BPH by TFL. During this session, you will have the opportunity to attend didactic presentations and observe live cases showcasing surgical techniques, helpful tips and tricks, and medical management strategies for stone patients.

EMS Successful PCNL with the Swiss LithoClast® Trilogy Max

12 December 2024
EMS and the Hospital team of Prof. Thomas Knoll in Sindelfingen, Germany are delighted to have you for our 1-day program focused on advanced techniques performing a successful PCNL. The session comprises a combination of didactic presentations and live case observation on surgical techniques, tips & tricks, and medical management of stone patients.

The Royal Marsden: Gynaecological Cancers 2-Day Conference

20 March 2025 -21 March 2025
Programme to reflect the breadth of professional expertise required to care for women with gynaecological cancers, and their diverse needs with an emphasis on practical skills. This study day is aimed at medical, nursing and allied health care professionals who are involved in the care of individuals with gynaecological cancer.

Patient decision aids in the management of stress urinary incontinence

9 March 2020 | | URO - Functional / Reconstructive Urology
Urinary incontinence is a common condition faced by up to 20-50% of women, which impairs quality of life and poses a significant socioeconomic burden to both the individual women involved and more widely to the NHS [1]. The overall cost...

Biomarkers in prostate cancer detection

1 July 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
Prostate cancer (PCa) is the second most common cancer in men with an estimated prevalence of 1.1 million worldwide in 2012. This heterogeneous disease resulted in approximately 307,000 deaths, making it the fifth leading cause of cancer-related death in men...